Titre : Caulobacteraceae

Caulobacteraceae : Questions médicales fréquentes

Nom anglais: Caulobacteraceae

Descriptor UI: D042063

Tree Number: B03.660.050.090

Termes MeSH sélectionnés :

Contrast Media

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Caulobacteraceae
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Caulobacteraceae : Questions médicales les plus fréquentes", "headline": "Caulobacteraceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Caulobacteraceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Caulobacteraceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alphaproteobacteria", "url": "https://questionsmedicales.fr/mesh/D020561", "about": { "@type": "MedicalCondition", "name": "Alphaproteobacteria", "code": { "@type": "MedicalCode", "code": "D020561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Caulobacter", "alternateName": "Caulobacter", "url": "https://questionsmedicales.fr/mesh/D016934", "about": { "@type": "MedicalCondition", "name": "Caulobacter", "code": { "@type": "MedicalCode", "code": "D016934", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050.090.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Caulobacter crescentus", "alternateName": "Caulobacter crescentus", "url": "https://questionsmedicales.fr/mesh/D016935", "about": { "@type": "MedicalCondition", "name": "Caulobacter crescentus", "code": { "@type": "MedicalCode", "code": "D016935", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050.090.100.100" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Caulobacteraceae", "alternateName": "Caulobacteraceae", "code": { "@type": "MedicalCode", "code": "D042063", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiaojun Yang", "url": "https://questionsmedicales.fr/author/Xiaojun%20Yang", "affiliation": { "@type": "Organization", "name": "College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Yuanping Li", "url": "https://questionsmedicales.fr/author/Yuanping%20Li", "affiliation": { "@type": "Organization", "name": "Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Renwei Feng", "url": "https://questionsmedicales.fr/author/Renwei%20Feng", "affiliation": { "@type": "Organization", "name": "Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Jian Chen", "url": "https://questionsmedicales.fr/author/Jian%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA." } }, { "@type": "Person", "name": "Hend A Alwathnani", "url": "https://questionsmedicales.fr/author/Hend%20A%20Alwathnani", "affiliation": { "@type": "Organization", "name": "Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Radiographic Contrast Media and the Kidney.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35777831", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2215/CJN.16311221" } }, { "@type": "ScholarlyArticle", "name": "[Contrast Media Toxicity and Its Prevention].", "datePublished": "2023-10-26", "url": "https://questionsmedicales.fr/article/38010244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Contrast media volume reduction with the DyeVert", "datePublished": "2023-09-05", "url": "https://questionsmedicales.fr/article/37668067", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ccd.30809" } }, { "@type": "ScholarlyArticle", "name": "Iodinated Contrast Media Conservation Measures During a Global Shortage: Effect on Contrast Media Use at a Large Health System.", "datePublished": "2022-06-22", "url": "https://questionsmedicales.fr/article/35731095", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2214/AJR.22.28080" } }, { "@type": "ScholarlyArticle", "name": "Strategies for calculating contrast media dose for chest CT.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37303003", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41747-023-00345-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Alphaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020561" }, { "@type": "ListItem", "position": 5, "name": "Caulobacteraceae", "item": "https://questionsmedicales.fr/mesh/D042063" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Caulobacteraceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Caulobacteraceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Caulobacteraceae", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D042063?mesh_terms=Contrast+Media#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale

Validation scientifique effectuée le 13/02/2025

Contenu vérifié selon les dernières recommandations médicales

En savoir plus sur Dr Menir

Sous-catégories

2 au total
└─

Caulobacter

Caulobacter D016934 - B03.660.050.090.100
└─└─

Caulobacter crescentus

Caulobacter crescentus D016935 - B03.660.050.090.100.100

Auteurs principaux

Xiaojun Yang

1 publication dans cette catégorie

Affiliations :
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Yuanping Li

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Renwei Feng

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Jian Chen

1 publication dans cette catégorie

Affiliations :
  • Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Publications dans "Caulobacteraceae" :

Hend A Alwathnani

1 publication dans cette catégorie

Affiliations :
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Publications dans "Caulobacteraceae" :

Weifeng Xu

1 publication dans cette catégorie

Affiliations :
  • Joint International Research Laboratory of Water and Nutrient in Crop, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Christopher Rensing

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Sources (10000 au total)

Contrast media volume reduction with the DyeVert

10 2023
DOI: 10.1002/ccd.30809 PMID: 37668067

Contrast associated acute kidney injury (CA-AKI) can lead to an increased risk of adverse events. Contrast media (CM) volume reduction has been advocated as a pivotal strategy to prevent CA-AKI in sta... To compare the effectiveness of CM volume reduction with the DyeVert... We prospectively collected data from 136 patients with stable coronary artery disease at high risk of CA-AKI treated with left ventricular end diastolic pressure (LVEDP)- guided hydration and undergoi... Patients in the DyeVert group were treated with a significant lower CM volume (median: 47.5 vs. 84.0 mL, p < 0.001). The trend in creatinine increase was lower (p = 0.004) and the Δ of creatinine (0-4... CM volume reduction with the DyeVert...

Humans Contrast Media Creatinine Treatment Outcome Acute Kidney Injury +4 autres

Strategies for calculating contrast media dose for chest CT.

12 06 2023
DOI: 10.1186/s41747-023-00345-w PMID: 37303003

Total body weight (TBW) is a frequently used contrast media (CM) strategy for dose calculation in enhanced CT, yet it is suboptimal as it lacks consideration of patient characteristics, such as body f... Eighty-nine adult patients referred for CM thoracic CT were retrospectively included, categorized as either normal, muscular, or overweight. Patient body composition data was used to calculate the CM ... BIA demonstrated the highest and lowest calculated CM dose in muscular and overweight groups respectively, compared to other strategies. For the normal group, the lowest calculated CM dose was achieve... The BIA method is more adaptive to variations in patient body habitus especially in muscular and overweight patients and is most closely correlated to patient demographics. This study could support ut... The BIA-based method is adaptive to variations in body habitus especially in muscular and overweight patients and is closely correlated to patient demographics for contrast-enhanced chest CT.... • Calculations based on BIA showed the largest variation in CM dose. • Lean body weight using BIA demonstrated the strongest correlation to patient demographics. • Lean body weight BIA protocol may be...

Adult Humans Contrast Media Overweight Retrospective Studies +2 autres

Impact of iodinated contrast media conserving interventions and lessons for the future.

Feb 2023
DOI: 10.1111/1754-9485.13458 PMID: 35856814

A severe shortage of iodinated contrast medium (ICM) has forced radiology departments around the world to implement strategies to reduce contrast utilization. The aim of this study was to evaluate the... Our radiology department instituted several ICM-conserving interventions on 13... The average daily number of CECT (all), CECT (inpatient and ED), CTPA, CECT AP, and 'Code stroke' CT scans decreased significantly (P < 0.01), by 58.6%, 68.8%, 74.1%, 88.0%, and 37.5%, respectively. T... Interventions in CT alone, focused on improving patient triage to CECT while avoiding deferment of any outpatient oncology studies, have achieved an approximately two-thirds reduction in ICM consumpti...

Humans Contrast Media Tomography, X-Ray Computed Computed Tomography Angiography Angiography +1 autres

Contrast media extravasation injury: a prospective observational cohort study.

25 Oct 2023
DOI: 10.1186/s40001-023-01444-5 PMID: 37880738

To identify the risk factors for moderate and severe contrast media extravasation and provide effective guidance to reduce the degree of extravasation injuries.... We observed 224 adult patients who underwent contrast media extravasation at Xiangya Hospital of Central South University, Hunan Provincial Maternal and Child Healthcare Hospital, and Xiangya Changde ... Among 224 patients, 0 (0%) had severe, 18 (8.0%) had moderate, and 206 (92.0%) had mild contrast media extravasation injury. Multivariate logistic regression analysis revealed malignant tumors (odds r... Risk factors for moderate contrast media extravasation injury are malignant tumors, iohexol, large-volume (> 50 mL) extravasation, and back-of-the-hand injection. Analysis of these risk factors can he... High-risk patients with extravasation support should choose the appropriate contrast media type, avoiding back-of-the-hand injections. We recommend that patients with cancer be implanted with a high-p...

Adult Humans Contrast Media Extravasation of Diagnostic and Therapeutic Materials Iohexol +3 autres

[The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media].

24 Oct 2022
DOI: 10.26442/0403660.2022.09.201845 PMID: 36286755

To assess the role of atorvastatin to the frequency of contrast-induced acute kidney injury (CI-AKI) in patients with cardiovascular diseases (CVD) undergoing computed tomography (CT) with intravenous... One hundred patients with CVD undergoing CT with with intravenous contrast media administration were included in prospective observational study (ClinicalTrials.gov ID NCT04666389). Patients were divi... CI-AKI was diagnosed in 4 (3.96%) patients. At the same time, it was not possible to establish statistically significant relationships (p0.05) between risk factors and the development of CI-AKI. Stati... Cardiovascular diseases may increase the risk of CI-AKI after computed tomography with intravenous contrast media administration. Therefore, it is recommended to evaluate the serum creatinine concentr...

Male Humans Middle Aged Atorvastatin Contrast Media +6 autres

Imaging human lung perfusion with contrast media: A meta-analysis.

Jul 2023
DOI: 10.1016/j.ejrad.2023.110850 PMID: 37178490

To pool and summarise published data of pulmonary blood flow (PBF), pulmonary blood volume (PBV) and mean transit time (MTT) of the human lung, obtained with perfusion MRI or CT to provide reliable re... PubMed was systematically searched to identify studies that quantified PBF/PBV/MTT in the human lung by injection of contrast agent, imaged by MRI or CT. Only data analysed by 'indicator dilution theo... PBV was obtained from 313 measurements from 14 publications (wM: 13.97 ml/100 ml, wSD: 4.21 ml/100 ml, wCoV 0.30). MTT was obtained from 188 measurements from 10 publications (wM: 5.91 s, wSD: 1.84 s ... Reference values for PBF, MTT and PBV were obtained in HV. The literature data are insufficient to draw strong conclusions regarding disease reference values....

Humans Contrast Media Lung Pulmonary Circulation Magnetic Resonance Imaging +1 autres